Stocksigma LogoStocksigma Logo

Gland Pharma Settles Stock Exchange Fines Over Director Appointment Delay

Gland Pharma Limited addressed exchange-levied fines of ₹70,000 each from BSE and NSE regarding a 34-day technical breach of Regulation 17(1A) under SEBI

Gland Pharma Settles Stock Exchange Fines Over Director Appointment Delay

Gland Pharma Ltd · Others (Uncategorized) · 13 Sept 2026, 8:57 pm

Gland Pharma Settles Stock Exchange Fines Over Director Appointment Delay Gland Pharma Limited addressed exchange-levied fines of ₹70,000 each from BSE and NSE regarding a 34-day technical breach of Regulation 17(1A) under SEBI LODR. The delay occurred while securing shareholder approval via postal ballot for appointing Non-Executive Independent Director Mr. William Keller, aged over 75, appointed on 15th Jun'26. Shareholders approved the special resolution on 18th Jul'26. The board reviewed the issue on 13th Sep'26, and the company has suo motu paid the full fine upfront to close the matter.

Original exchange filing (PDF)

More announcements from Gland Pharma Ltd

All Gland Pharma Ltd announcements